Catalyst Wire Dossier Catalyst Wire Dossier

Saflutan

tafluprost · Santen Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Saflutan, covering 2015-04-23 to 2015-04-23. Get the full timeline:

Most recent: Clinical Trial Update: An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More [Phase 4]

See pricing